DARVOCET, DARVON AND PROPOXYPHENE PRODUCTS LIABILITY LITIGATION MDL 2226 TRANSFER ORDER


	You will be connected directly to a DrugSettlement representative.

warning: Parameter 2 to flowplayer3_swftools_flashvars() expected to be a reference, value given in /var/www/pressflow/includes/module.inc on line 450.

Do you believe that you have a claim? Fill out this form to have a lawyer contact you.

Your name: *	Your email address: *	Cause of Injury: *
Your address (part 1):	(part 2):	City:
Zip: State: *	Phone#: *	How did you find DrugSettlement.com?: *
Please enter any information you'd like us to know: *

DARVOCET, DARVON AND PROPOXYPHENE PRODUCTS LIABILITY LITIGATION MDL 2226 TRANSFER ORDER

Submitted by R. M. Waters on Wed, 08/17/2011 - 20:10

Darvon/Darvocet

On August 16, 2011 the United States Judicial Panel on Multidistrict Litigation ordered that all pending federal cases involving injuries or deaths alleged to have been caused by the use of Darvocet, Darvon or generic Propoxyphene would be consolidated in MDL 2226. The Court accepted the defendants first choice of the Eastern District of Kentucky as site of the MDL. Pending cases have been transferred to the Eastern District of Kentucky (Covington Division) and assigned to the Honorable Danny C. Reeves for coordinated or consolidated pretrial proceedings.